DOI: https://doi.org/10.18524/2304-0947.2016.1(57).67512
ІНДЕНО[1,2,3-de]ФТАЛАЗІН-3(2H)-ОН ТА ЙОГО АНАЛОГИ – СИНТЕЗ ТА ПРОТИЗАПАЛЬНІ ВЛАСТИВОСТІ
Анотація
Ключові слова
Повний текст:
PDFПосилання
Bogoyevitch M.A., Boehm I., Oakley A., Ketterman A.J., Barr R.K. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochimica et Biophysica Acta (BBA) -
Proteins and Proteomics, 2004, vol. 1697, no 1 – 2, pp. 89 – 101. doi:10.1016/j.bbapap.2003.11.016
Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA, 2001, vol. 98, no 24, pp. 13681 – 13686. doi:10.1124/dmd.31.11.1279
Pereira A.C.P., Soares-Martins J.A.P., Leite F.G.G., Da Cruz A.F.P., Torres A.A., Souto-Padrón T., Kroon E.G., Ferreira P.C.P., Bonjardim C.A. SP600125 inhibits Orthopoxviruses replication in a JNK1/2 -independent manner: Implication as a potential antipoxviral. Antiviral Res, 2012, V. 93, no 1. pp. 69 – 77. doi:10.1016/j.antiviral.2011.10.020
Nacken W., Ehrhardt C., Ludwig S. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.Biol. Chem, 2012, vol. 393, no 6, pp. 525 – 534. doi: 10.1515/hsz-2011-0270
Zhang H., Niu X., Qian Z., Qian J., Xuan B. The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication. J.Med.Virol, 2015, vol. 87, no 12, pp. 2135 – 2144. doi:10.1002/jmv.24286
Marozin S., Altomonte J., Apfel S., Dinh P.X., De Toni E.N., Rizzani A., Nissler A., Kato N., Schmid R.M., Pattnaik A.K., Ebert O. Posttranslational Modification of Vesicular Stomatitis Virus
Glycoprotein, but Not JNK Inhibition, Is the Antiviral Mechanism of SP600125. J.Virol, 2012, vol.86, no 9, pp. 4844 – 4855. doi:10.1128/JVI.06649-11
Nazarov V.N. Policiklicheskie aromaticheskie uglevodorody v sinteze biologicheski aktivnyh veshhestv: Monografija [Polycyclic aromatic hydrocarbons in the synthesis of biologically active substances].– H.: «BET», 2013. 166 p.
Slovar' organicheskih soedinenij. Stroenie. Fizicheskie i himicheskie svojstva vazhnejshih organicheskih soedinenij i ih proizvodnyh. Tom 2: Eccaine – Myrtillin chloride [Dictionary of Organic Compounds. The constitutions and physical and chemical properties of the principle carbon compounds and their derivatives. Vol 2: Eccaine – Myrtillin chloride]. / Pod red. I.Hejl'borna, G.M. Bjenberi. –M.: Inostrannaja literatura, 1949. 891p. (in Russian)
Fekry Ismail M., El-Bassiouny F.A., Younes H.A. New convenient one-step synthesis of 4-arylphthalaz-1-ones. Tetrahedron, 1984, vol. 40, no 15, pp. 2983 – 2984.
Wharton C.J., Wrigglesworth R. Synthesis and reactions of 2,3-dihydro-oxazolo[2,3-a]isoindol- 5(9bH)-ones. J. Chem. Soc., Perkin Trans.1, 1985, pp. 809 – 813.
Tóth G.R., Molnár S., Tamás T., Borbély I. An Efficient Synthesis of 4,5-Dihydro-3(2H)-pyridazinone Derivatives. Synthetic Communications, 1997, vol. 27, no 20, pp. 3513 – 3523.
Reichelt I., Reissig H.U. Eine einfache und flexible Synthese fur 4,5-Dihydro-2H-3-pyridazinone. Synthesis, 1984, no 9, pp. 786 – 787.
Scapin G., Patel S.B., Lisnock J.M., Becker J.W., LoGrasso P.V. The Structure of JNK3 in Complex with Small Molecule Inhibitors: Structural Basis for Potency and Selectivity. Chem. Biol, 2003, vol. 10, no 8, pp. 705 – 712. (http://www.rcsb.org/pdb/files/1PMV.pdb)
Schepetkin I.A., Kirpotina L.N., Khlebnikov A.I., Hanks T.S., Kochetkova I., Pascual D.W., Jutila M.A., Quinn M.T. Identification and Characterization of a Novel Class of c-Jun N-terminal Kinase Inhibitors. Mol. Pharmacol, 2012, vol. 81, № no 6, pp. 832 – 845. doi:10.1124/mol.111.077446
Fabian M.A., Biggs W.H., III, Treiber D.K., Atteridge C.E., Azimioara M.D., Benedetti M.G., Carter T.A., Ciceri P., Edeen P.T., Floyd M., Ford J.M., Galvin M., Gerlach J.L., Grotzfeld R.M.,
Herrgard S., Insko D.E., Insko M.A., Lai A.G., Lelias J.M., Mehta S.A., Milanov Z.V., Velasco A.M., Wodicka L.M., Patel H.K., Zarrinkar P.P., Lockhart D.J. A small molecule-kinase interaction
map for clinical kinase inhibitors. Nat Biotechnol, 2005, vol. 23, no 3, pp. 329 – 336. doi:10.1038/nbt1068
Пристатейна бібліографія ГОСТ
1. Bogoyevitch M.A., Boehm I., Oakley A., Ketterman A.J., Barr R.K. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. // Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics. – 2004. – Vol. 1697, N 1 – 2. P. 89 – 101. doi:10.1016/j.bbapap.2003.11.016
2. Bennett B.L., Sasaki D.T., Murray B.W., O’Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. // Proc. Natl. Acad. Sci. USA. – 2001. – Vol. 98, № 24. – P. 13681 – 13686. doi:10.1124/dmd.31.11.1279
3. Pereira A.C.P., Soares-Martins J.A.P., Leite F.G.G., Da Cruz A.F.P., Torres A.A., Souto-Padrón T., Kroon E.G., Ferreira P.C.P., Bonjardim C.A. SP600125 inhibits Orthopoxviruses replication in a JNK1/2 -independent man-ner: Implication as a potential antipoxviral. // Antiviral Res. – 2012. – V. 93, № 1. – P. 69 – 77. doi:10.1016/j.antiviral.2011.10.020
4. Nacken W., Ehrhardt C., Ludwig S. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. // Biol. Chem. –2012. – Vol. 393, № 6. – P. 525 – 534. doi: 10.1515/hsz-2011-0270
5. Zhang H., Niu X., Qian Z., Qian J., Xuan B. The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication. // J. Med. Virol. – 2015. – Vol. 87, № 12. – P. 2135 – 2144. doi: 10.1002/jmv.24286
6. Marozin S., Altomonte J., Apfel S., Dinh P.X., De Toni E.N., Rizzani A., Nűssler A., Kato N., Schmid R.M., Pattnaik A.K., Ebert O. Posttranslational Modification of Vesicular Stomatitis Virus Glycoprotein, but Not JNK Inhibition, Is the Antiviral Mechanism of SP600125 // J. Virol. – 2012. – Vol. 86, № 9. – P. 4844 – 4855.
doi:10.1128/JVI.06649-11
7. Назаров В.Н. Полициклические ароматические углеводороды в синтезе биологически активных веществ: Монография. – Х.: «БЭТ», 2013. – 166с.
8. Словарь органических соединений. Строение. Физические и химические свойства важнейших органических соединений и их производных. Том 2: Eccaine – Myrtillin chloride. / Под ред. И.Хейльборна, Г.М.Бэнбери.–М.: Иностранная литература, 1949. – 891с.
9. Fekry Ismail M., El-Bassiouny F.A., Younes H.A. New convenient one-step synthesis of 4-arylphthalaz-1-ones
// Tetrahedron. – 1984. – Vol. 40, № 15. – P. 2983 – 2984. doi:10.1016/S0040-4020(01)91312-2
10. Wharton C.J., Wrigglesworth R. Synthesis and reactions of 2,3-dihydro-oxazolo[2,3-a]isoindol-5(9bH)-ones // J. Chem. Soc., Perkin Trans.1. – 1985. – P. 809 – 813. doi: 10.1039/P19850000809
11. Tóth G.R., Molnár S., Tamás T., Borbély I. An Efficient Synthesis of 4,5-Dihydro-3(2H)-pyridazinone Derivatives
// Synthetic Communications. – 1997. – V. 27, № 20. – P. 3513 – 3523. doi: 10.1080/00397919708007072
12. Reichelt I., Reissig H.U. Eine einfache und flexible Synthese fur 4,5-Dihydro-2H-3-pyridazinone // Synthesis. – 1984., № 9. – P. 786 – 787.
13. Scapin G., Patel S.B., Lisnock J.M., Becker J.W., LoGrasso P.V. The Structure of JNK3 in Complex with Small Molecule Inhibitors: Structural Basis for Potency and Selectivity. // Chem. Biol. – 2003. – Vol. 10, № 8. – P.705 – 712. doi:10.1016/S1074-5521(03)00159-5 (http://www.rcsb.org/pdb/files/1PMV.pdb)
14. Schepetkin I.A., Kirpotina L.N., Khlebnikov A.I., Hanks T.S., Kochetkova I., Pascual D.W., Jutila M.A., Quinn M.T. Identification and Characterization of a Novel Class of c-Jun N-terminal Kinase Inhibitors. // Mol. Pharmacol.– 2012. – Vol. 81, № 6. – P. 832 – 845. doi:10.1124/mol.111.077446
15. Fabian M.A., Biggs W.H., III, Treiber D.K., Atteridge C.E., Azimioara M.D., Benedetti M.G., Carter T.A., Ciceri P., Edeen P.T., Floyd M., Ford J.M., Galvin M., Gerlach J.L., Grotzfeld R.M., Herrgard S., Insko D.E., Insko M.A., Lai A.G., Lelias J.M., Mehta S.A., Milanov Z.V., Velasco A.M., Wodicka L.M., Patel H.K., Zarrinkar P.P., Lockhart D.J. A small molecule-kinase interaction map for clinical kinase inhibitors. // Nat. Biotechnol. –2005. – Vol. 23, № 3. – P. 329 – 336. doi:10.1038/nbt1068

Ця робота ліцензована Creative Commons Attribution-ShareAlike 4.0 International License.